Adam Stone

Mr. Stone has been a member of Renovia’s Board since May 2017. In 2006, Mr. Stone joined Perceptive Advisors. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there he focused on biotech and specialty pharmaceuticals. He graduated, with honors, from Princeton University with a B.A. in molecular biology. Mr. Stone serves on the board of directors for several other Perceptive portfolio companies, including Solid Biosciences, and Xontogeny. Additionally, Adam serves as the CEO of ARYA Sciences Acquisition Corp, and he is a member of Perceptive’s internal investment committees for the credit opportunities and venture funds.